Article ID Journal Published Year Pages File Type
8243943 International Journal of Radiation Oncology*Biology*Physics 2006 8 Pages PDF
Abstract
Conclusions: Prostatic specific antigen doubling time is significantly associated with CSS, but did not meet all of Prentice's requirements for a surrogate endpoint of CSS. Thus, the risk of dying of prostate cancer is not fully explained by PSADT.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
Posttreatment prostatic-specific antigen doubling time as a surrogate endpoint for prostate cancer-specific survival: An analysis of Radiation Therapy Oncology Group Protocol 92-02
Authors
, , , , , , , ,